What are the dermatologic signs and symptoms of hyperthyroidism?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: June 14, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Dermatologic Signs and Symptoms of Hyperthyroidism

The most common dermatologic manifestations of hyperthyroidism include warm, moist, smooth skin with increased sweating, pruritus (itching), alopecia (hair loss), onycholysis (nail separation), and in approximately 5% of Graves' disease cases, pretibial myxedema (thyroid dermopathy).

Primary Skin Manifestations

General Cutaneous Changes

The skin in hyperthyroidism characteristically becomes:

  • Warm and moist due to increased peripheral blood flow and excessive sweating
  • Smooth and soft with a velvety texture 1
  • Flushed with increased vascularity

These changes reflect the hypermetabolic state and are among the earliest visible signs of thyroid hormone excess 2.

Pruritus (Itching)

  • Occurs in approximately 6.4% of hyperthyroid patients 3
  • Can be the sole presenting complaint and may delay diagnosis if thyroid disease is not considered 3
  • Resolves quickly once euthyroid status is achieved 3

Hair Changes

  • Alopecia affects approximately 2.6% of patients 3
  • Hair becomes fine, soft, and fragile 1
  • May paradoxically worsen with antithyroid medication initiation in some patients 3

Nail Changes

  • Onycholysis (separation of nail from nail bed) is a characteristic finding 1, 3
  • Nails become soft and fragile 1
  • May see increased nail growth rate

Specific Graves' Disease Manifestations

Pretibial Myxedema (Thyroid Dermopathy)

This occurs in approximately 5% of Graves' disease cases and represents a specific autoimmune manifestation 4:

  • Typical presentation: Non-pitting edema with "orange peel" appearance on the shins

  • Associated features:

    • Usually occurs in severe Graves' disease
    • More common in smokers
    • Often accompanies moderate-to-severe orbitopathy
    • May develop after radioiodine therapy
    • Always associated with elevated TSH-receptor antibodies 4
  • Clinical variants: Can present as nodular, hypertrophic, or rarely elephantiasis-like forms

  • Treatment approach 4:

    • Must be initiated early for effectiveness
    • Class 4 topical corticosteroids under occlusive dressing (plastic seal)
    • Apply once daily (preferably overnight) for 4-10 weeks initially
    • Continue for several weeks to months even after improvement
    • Caution: Biopsy is contraindicated due to risk of trauma-related worsening 4

Less Common Manifestations

Hyperpigmentation

  • Can occur on lower extremities, particularly shins, backs of feet, and nail beds 5
  • Histologically shows basal melanosis and hemosiderin deposition around dermal capillaries and sweat glands
  • Key distinction from Addison's disease: Distribution pattern, hemosiderin deposition, and poor response to treatment of hyperthyroidism 5

Associated Conditions

Lower prevalence findings include 3:

  • Vitiligo
  • Urticaria
  • Eczema
  • Xanthelasma

Clinical Pitfalls

Important caveat: Dermatologic symptoms can be the sole presenting complaint and may delay diagnosis if thyroid disease is not considered in the differential 3. When patients present with unexplained pruritus, alopecia, or characteristic nail changes, thyroid function testing should be performed.

The cutaneous manifestations typically resolve quickly with achievement of euthyroid status, except for pretibial myxedema which requires specific treatment and may persist despite thyroid hormone normalization 4, 3.

References

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.